相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists
Paul Galatsis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo
Anthony C. Vernon et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonists
John A. Wendt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists
Jared B. J. Milbank et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Fragile X syndrome: Assessment and treatment implications
Allan L. Reiss et al.
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2007)
Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs
Agnieszka Palucha et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Group I metabotropic glutamate receptors: A role in neurodevelopmental disorders?
Maria Vincenza Catania et al.
MOLECULAR NEUROBIOLOGY (2007)
Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment
Bhomraj Thanvi et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator
Matthias T. Wyss et al.
NEUROIMAGE (2007)
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease
Flora Mela et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Comparison of the effects of mGluR1 and mGluR5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice
Jolanta Kotlinska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Rational design, synthesis, and structure-activity relationship of benzoxazolones: New potent mglu5 receptor antagonists based on the fenobam structure
Siniona M. Ceccarelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Synthesis and biological evaluation of fenobam analogs as mGlu5 receptor antagonists
Georg Jaeschke et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The role of metabotropic glutamate receptors in drug reward, motivation and dependence
Athina Markou
DRUG NEWS & PERSPECTIVES (2007)
Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: Implications for medication studies
Peter S. Jensen et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)
Peripheral versus central modulation of gastric vagal pathways by metabotropic glutamate receptor 5
Richard L. Young et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors:: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies
Samuel Hintermann et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors
Hans Brauner-Osborne et al.
CURRENT DRUG TARGETS (2007)
Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism
Michael S. Cowen et al.
PSYCHOPHARMACOLOGY (2007)
Recent advances in understanding migraine mechanisms, molecules and therapeutics
Peter J. Goadsby
TRENDS IN MOLECULAR MEDICINE (2007)
Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications
Peter Bach et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2007)
Antiaggressive effects of MPEP, a selective antagonist of mGlu5 receptors, in agonistic interactions between male mice
Jose Francisco Navarro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Potentiation of mouse vagal afferent mechanosensitivity by ionotropic and metabotropic glutamate receptors
James A. Slattery et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
In vitro and in vivo evaluation of [11C]MPEPy as a potential PET ligand for mGlu5 receptors
Alin J. Severance et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
Metabotropic glutamate receptors
Francesco Ferraguti et al.
CELL AND TISSUE RESEARCH (2006)
Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice
Xia Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5)
Peter Bach et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5)
Peter Bach et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats
Olga A. Dravolina et al.
PSYCHOPHARMACOLOGY (2006)
Comparison of the binding pockets of two chemically unrelated allosteric antagonists of the mGlu5 receptor and identification of crucial residues involved in the inverse agonism of MPEP
Pari Malherbe et al.
JOURNAL OF NEUROCHEMISTRY (2006)
mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy
Wolfgang Loescher et al.
NEUROPHARMACOLOGY (2006)
Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat models of anxiety
Miguel Perez de la Mora et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Structure-activity relationship of thiopyrimidines as mGluR5 antagonists
LG Hammerland et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease
MT Armentero et al.
NEUROBIOLOGY OF DISEASE (2006)
Overactive bladder: A better understanding of pathophysiology, diagnosis and management
AJ Wein et al.
JOURNAL OF UROLOGY (2006)
Phenyl ureas of creatinine as mGluR5 antagonists.: A structure-activity relationship study of fenobam analogues
A Wållberg et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice
CW Hodge et al.
PSYCHOPHARMACOLOGY (2006)
Transcription, translation and fragile X syndrome
Kathryn Garber et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2006)
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
QJ Yan et al.
NEUROPHARMACOLOGY (2005)
Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism
A Oueslati et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Fenobam:: A clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity
RHP Porter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems
MS Cowen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task
T Steckler et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease
AC Vernon et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Beyond monoamines: Glutamatergic function in mood disorders
A Kugaya et al.
CNS SPECTRUMS (2005)
Dipyridyl amines: Potent metabotropic glutamate subtype 5 receptor antagonists
TM Kamenecka et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist
J Jensen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands
CL Frisby et al.
GASTROENTEROLOGY (2005)
Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors
MX Yu et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Therapeutic implications of the mGluR theory of fragile X mental retardation
MF Bear
GENES BRAIN AND BEHAVIOR (2005)
Antidepressant effect of ketamine during ECT
R Ostroff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Allosteric functioning of dimeric class C G-protein-coupled receptors
JP Pin et al.
FEBS JOURNAL (2005)
The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats
JP Schroeder et al.
PSYCHOPHARMACOLOGY (2005)
The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats
NE Paterson et al.
PSYCHOPHARMACOLOGY (2005)
The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison
TM Ballard et al.
PSYCHOPHARMACOLOGY (2005)
Role of central and peripheral mGluR5 receptors in post-operative pain in rats
CZ Zhu et al.
PAIN (2005)
Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: Comparison with dizocilpine
B Lee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists
C Bonnefous et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats
K Rasmussen et al.
NEUROPHARMACOLOGY (2005)
Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications
A Slassi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain
JS Han et al.
PAIN (2005)
Anticonvulsant action of an antagonist of metabotropic glutamate receptors mGluR5 MPEP in immature rats
D Loikova et al.
NEUROPHARMACOLOGY (2005)
Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats
AY Bespalov et al.
NEUROPHARMACOLOGY (2005)
In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling
JM Wieronska et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking
M Tessari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity
J Roppe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABAA signaling
A Klodzinska et al.
NEUROPHARMACOLOGY (2004)
Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the development of morphine-induced rewarding effect in mice
T Aoki et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-2,3′-bipyridine:: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity
JR Roppe et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies
BR Thanvi et al.
POSTGRADUATE MEDICAL JOURNAL (2004)
Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities
CZ Zhu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice
AJ Mcgeehan et al.
PSYCHOPHARMACOLOGY (2004)
Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells
VJ Collett et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity
ND Smith et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
3-[3-fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine:: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist
SF Poon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists
MP Johnson et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
MPEP, an antagonist of metabotropic glutamate receptors, exhibits anticonvulsant action in immature rats without a serious impairment of motor performance
P Mares et al.
EPILEPSY RESEARCH (2004)
mGluS receptor antagonists: A novel class of anxiolytics?
W Spooren et al.
DRUG NEWS & PERSPECTIVES (2004)
mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior
P Bäckström et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Gene structure of the human metabotropic glutamate receptor 5 and functional analysis of its multiple promoters in neuroblastoma and astroglioma cells
C Corti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Glutamate metabotropic receptors as targets for drug therapy in epilepsy
RX Moldrich et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice
NE Paterson et al.
PSYCHOPHARMACOLOGY (2003)
The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse
AJ McGeehan et al.
SYNAPSE (2003)
Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist
P Popik et al.
NEUROPHARMACOLOGY (2002)
Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats
A Pilc et al.
NEUROPHARMACOLOGY (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats
JM Wieronska et al.
AMINO ACIDS (2002)
Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats
K Ossowska et al.
NEUROPHARMACOLOGY (2001)
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
C Chiamulera et al.
NATURE NEUROSCIENCE (2001)
Novel allosteric antagonists shed light on mglu5 receptors and CNS disorders
WPJM Spooren et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy
E Aronica et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2001)
Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery
E Aronica et al.
EPILEPSY RESEARCH (2001)
Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain
K Walker et al.
NEUROPHARMACOLOGY (2001)
mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia
K Walker et al.
NEUROPHARMACOLOGY (2001)
Effects of the prototypical mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats
WPJM Spooren et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893)
AG Chapman et al.
NEUROPHARMACOLOGY (2000)
分享论文
